Merck's Q4 profit falls 7 pct on charges, generic competition to blockbuster allergy medicine

  • by: LINDA A. JOHNSON , Associated Press
  • Updated: February 1, 2013 - 3:08 PM

Merck & Co.'s fourth-quarter profit fell 7 percent because of hits from generic competition and one-time charges, and the company pushed back plans for seeking approval of a key experimental osteoporosis drug.

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters

ADVERTISEMENT

Advertisement
Golden Gavel by Star Tribune

Time left for great deals

Bid thru Sept. 29

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT